News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Pfizer cancer drug wins special status; shares jump

Started by riky, April 11, 2013, 09:00:20 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Pfizer cancer drug wins special status; shares jump

<p><a href="http://news.yahoo.com/pfizer-breast-cancer-drug-wins-breakthrough-status-shares-162330753--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/r9kLaEIyGWoIeo52SHiQqw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-04-10T162330Z_1_CBRE93919JA00_RTROPTP_2_PFIZER.JPG" width="130" height="86" alt="A woman walks past the Pfizer Inc. headquarters in New York" align="left" title="A woman walks past the Pfizer Inc. headquarters in New York" border="0" /></a>By Ransdell Pierson (Reuters) - U.S. regulators have granted a &quot;breakthrough therapy&quot; designation to an experimental Pfizer Inc treatment for breast cancer, lifting the company's shares and putting a spotlight on its growing cancer-drug portfolio. Analysts from JPMorgan and Leerink Swann forecast the oral medicine, called palbociclib, could generate annual sales of $5 billion or more if it is approved for use against breast cancer as well as other types of cancer. Pfizer, whose stock rose 2.6 percent, said the U.S. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login